Author

Chuck Z. Li

Institution: Keymed Biosciences Inc. (China)

Observed institution: Keymed Biosciences Inc. (China)

ORCID: 0000-0001-5564-0433

Observed ORCID: 0000-0001-5564-0433

OpenAlex ID: A5024649907

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

2022 · Mark L. Sandberg, Xueyin Wang, et al. · Science Translational Medicine · 66

A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy

2022 · Xueyin Wang, Lu Min Wong, et al. · Toxicology and Applied Pharmacology · 6

Abstract 2751: The modular Tmod dual_receptor system exploits tumor deletions to achieve robust tumor-selective cytotoxicity

2022 · Han Xu, Agnes Hamburger, et al. · Cancer Research

Works count: 3

Citation count: 72

H-index: 2

I10-index: 1